Bioretec Oy
OMXH:BRETEC

Watchlist Manager

Bioretec Oy

OMXH:BRETEC

Watchlist

Dividends

Price: 2.14 EUR 7% Market Closed

Market Cap: 49.9m EUR

Have any thoughts about
Bioretec Oy?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	UnitedHealth Group Inc NYSE:UNH	Health Care
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Walmart Inc NYSE:WMT	Retail
US	Verizon Communications Inc NYSE:VZ	Telecommunication

Add Price Alert

Price Target:

Last Price: 2.14 EUR

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

BRETEC Alert

Bioretec Oy

2.14

+0.14 (+7%)

52 Week Range	1.82 2.94
Price Target

We'll email you a reminder when the closing price reaches EUR.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Berkshire Hathaway Inc NYSE:BRK.A	US
	Bank of America Corp NYSE:BAC	US
	Mastercard Inc NYSE:MA	US
	UnitedHealth Group Inc NYSE:UNH	US
	Exxon Mobil Corp NYSE:XOM	US
	Pfizer Inc NYSE:PFE	US
	Palantir Technologies Inc NYSE:PLTR	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Walmart Inc NYSE:WMT	US
	Verizon Communications Inc NYSE:VZ	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Bioretec Oy

What unique competitive advantages
does Bioretec Oy hold over its rivals?

What risks and challenges
does Bioretec Oy face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Bioretec Oy.

What unique competitive advantages
does Bioretec Oy hold over its rivals?

What risks and challenges
does Bioretec Oy face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Bioretec Oy.

Provide P/S
for Bioretec Oy.

Provide P/E
for Bioretec Oy.

Provide P/OCF
for Bioretec Oy.

Provide P/FCFE
for Bioretec Oy.

Provide P/B
for Bioretec Oy.

Provide EV/S
for Bioretec Oy.

Provide EV/GP
for Bioretec Oy.

Provide EV/EBITDA
for Bioretec Oy.

Provide EV/EBIT
for Bioretec Oy.

Provide EV/OCF
for Bioretec Oy.

Provide EV/FCFF
for Bioretec Oy.

Provide EV/IC
for Bioretec Oy.

Show me price targets
for Bioretec Oy made by professional analysts.

What are the Revenue projections
for Bioretec Oy?

How accurate were the past Revenue estimates
for Bioretec Oy?

What are the Net Income projections
for Bioretec Oy?

How accurate were the past Net Income estimates
for Bioretec Oy?

What are the EPS projections
for Bioretec Oy?

How accurate were the past EPS estimates
for Bioretec Oy?

What are the EBIT projections
for Bioretec Oy?

How accurate were the past EBIT estimates
for Bioretec Oy?

Compare the revenue forecasts
for Bioretec Oy with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Bioretec Oy and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Bioretec Oy against its competitors.

Analyze the profit margins
(gross, operating, and net) of Bioretec Oy compared to its peers.

Compare the P/E ratios
of Bioretec Oy against its peers.

Discuss the investment returns and shareholder value creation
comparing Bioretec Oy with its peers.

Analyze the financial leverage
of Bioretec Oy compared to its main competitors.

Show all profitability ratios
for Bioretec Oy.

Provide ROE
for Bioretec Oy.

Provide ROA
for Bioretec Oy.

Provide ROIC
for Bioretec Oy.

Provide ROCE
for Bioretec Oy.

Provide Gross Margin
for Bioretec Oy.

Provide Operating Margin
for Bioretec Oy.

Provide Net Margin
for Bioretec Oy.

Provide FCF Margin
for Bioretec Oy.

Show all solvency ratios
for Bioretec Oy.

Provide D/E Ratio
for Bioretec Oy.

Provide D/A Ratio
for Bioretec Oy.

Provide Interest Coverage Ratio
for Bioretec Oy.

Provide Altman Z-Score Ratio
for Bioretec Oy.

Provide Quick Ratio
for Bioretec Oy.

Provide Current Ratio
for Bioretec Oy.

Provide Cash Ratio
for Bioretec Oy.

What is the historical Revenue growth
over the last 5 years for Bioretec Oy?

What is the historical Net Income growth
over the last 5 years for Bioretec Oy?

What is the current Free Cash Flow
of Bioretec Oy?

Discuss the annual earnings per share (EPS)
trend over the past five years for Bioretec Oy.

Section:

Wall Street
Price Targets

BRETEC Price Targets Summary
Bioretec Oy

Wall Street analysts forecast BRETEC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BRETEC is 2.45 EUR with a low forecast of 2.42 EUR and a high forecast of 2.52 EUR.

BRETEC Lowest Forecast

Wall Street Target

2.42 EUR

13% Upside

BRETEC Average Forecast

Wall Street Target

2.45 EUR

14% Upside

BRETEC Highest Forecast

Wall Street Target

2.52 EUR

18% Upside

Lowest

Price Target

2.42 EUR

13% Upside

Average

Price Target

2.45 EUR

14% Upside

Highest

Price Target

2.52 EUR

18% Upside

Bioretec Oy Competitors:
Price Targets

LNSR

LENSAR Inc

29% Upside

301367

BMC Medical Co Ltd

16% Upside

MEDI

Medistim ASA

17% Upside

TCMD

Tactile Systems Technology Inc

22% Upside

LNSR

LENSAR Inc

29% Upside

301367

BMC Medical Co Ltd

16% Upside

MEDI

Medistim ASA

17% Upside

TCMD

Tactile Systems Technology Inc

22% Upside

BDX

Becton Dickinson and Co

25% Upside

6849

Nihon Kohden Corp

11% Upside

7575

Japan Lifeline Co Ltd

3% Upside

NPCE

Neuropace Inc

44% Upside

Revenue
Forecast

Revenue Estimate
Bioretec Oy

For the last 4 years the compound annual growth rate for Bioretec Oy's revenue is 22%. The projected CAGR for the next 3 years is 70%.

22%

Past Growth

70%

Estimated Growth

N/A

Estimates Accuracy

N/A

Average

What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Bioretec Oy

N/A

Past Growth

N/A

Estimated Growth

N/A

Estimates Accuracy

N/A

Average

What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Bioretec Oy

N/A

Past Growth

N/A

Estimated Growth

N/A

Estimates Accuracy

N/A

Average

What are analyst estimates?

What is BRETEC's stock price target?

Price Target
2.45 EUR

According to Wall Street analysts, the average 1-year price target for BRETEC is 2.45 EUR with a low forecast of 2.42 EUR and a high forecast of 2.52 EUR.

What is Bioretec Oy's Revenue forecast?

Projected CAGR
70%

For the last 4 years the compound annual growth rate for Bioretec Oy's revenue is 22%. The projected CAGR for the next 3 years is 70%.

	Franklin Covey Co NYSE:FC	36.645 USD 0.95%
	Mohawk Industries Inc NYSE:MHK	119.38 USD -0.13%
	Ardmore Shipping Corp NYSE:ASC	12.09 USD 1.77%
	ASGN Inc NYSE:ASGN	83.95 USD 0.47%
	Skyworks Solutions Inc NASDAQ:SWKS	90.35 USD 0.18%
	Weatherford International PLC NASDAQ:WFRD	67.61 USD 1.26%

	Johnson & Johnson NYSE:JNJ	145.85 USD 0.4%
	Bank of America Corp NYSE:BAC	44.38 USD 1.12%
	Mastercard Inc NYSE:MA	535.71 USD 1.28%
	Salesforce Inc NYSE:CRM	344.43 USD 0.45%
	Abbvie Inc NYSE:ABBV	180 USD 0.9%
	Home Depot Inc NYSE:HD	396.14 USD 0.99%

	Arista Networks Inc NYSE:ANET	114.02 USD 0.82%
	Visa Inc NYSE:V	320.65 USD 1.08%
	Texas Pacific Land Corp NYSE:TPL	1 161.2 USD 1.91%
	KLA Corp NASDAQ:KLAC	650.53 USD 1.12%
	Manhattan Associates Inc NASDAQ:MANH	282.27 USD 1.24%
	Pinduoduo Inc NASDAQ:PDD	99.72 USD -0.86%

	Salesforce Inc NYSE:CRM	344.43 USD 0.45%
	Accenture PLC NYSE:ACN	360.93 USD 0.6%
	ServiceNow Inc NYSE:NOW	1 110.05 USD 2%
	EOG Resources Inc NYSE:EOG	120.83 USD 0.82%
	Copart Inc NASDAQ:CPRT	59.11 USD 1.29%
	Applied Materials Inc NASDAQ:AMAT	168.37 USD 0.54%

Bioretec Oy
OMXH:BRETEC